Postoperative Wound Sepsis Following Major Lower Extremity Amputations in Patients with Diabetes : Case - Control Study = إنتان جروح ما بعد عمليات البتر الكبرى في الطرف السفلي عند مرضى السكري

2014 ◽  
Vol 50 (3) ◽  
pp. 129-136
Author(s):  
Omer A. A. Abdel Sadiq ◽  
Mohamed ElMakki Ahmed ◽  
Aamir A. Hamza
2015 ◽  
Vol 3 (1) ◽  
pp. e000069 ◽  
Author(s):  
Claire M Buckley ◽  
Fauzi Ali ◽  
Graham A Roberts ◽  
Patricia M Kearney ◽  
Ivan J Perry ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Francisco Félix Caballero ◽  
Ellen A. Struijk ◽  
Alberto Lana ◽  
Antonio Buño ◽  
Fernando Rodríguez-Artalejo ◽  
...  

AbstractElevated concentrations of acylcarnitines have been associated with higher risk of obesity, type 2 diabetes and cardiovascular disease. The aim of the present study was to assess the association between L-carnitine and acylcarnitine profiles, and 2-year risk of incident lower-extremity functional impairment (LEFI). This case–control study is nested in the Seniors-ENRICA cohort of community-dwelling older adults, which included 43 incident cases of LEFI and 86 age- and sex- matched controls. LEFI was assessed with the Short Physical Performance Battery. Plasma L-carnitine and 28 acylcarnitine species were measured. After adjusting for potential confounders, medium-chain acylcarnitines levels were associated with 2-year incidence of LEFI [odds ratio per 1-SD increase: 1.69; 95% confidence interval: 1.08, 2.64; p = 0.02]. Similar results were observed for long-chain acylcarnitines [odds ratio per 1-SD increase: 1.70; 95% confidence interval: 1.03, 2.80; p = 0.04]. Stratified analyses showed a stronger association between medium- and long-chain acylcarnitines and incidence of LEFI among those with body mass index and energy intake below the median value. In conclusion, higher plasma concentrations of medium- and long-chain acylcarnitines were associated with higher risk of LEFI. Given the role of these molecules on mitochondrial transport of fatty acids, our results suggest that bioenergetics dysbalance contributes to LEFI.


Trauma ◽  
2020 ◽  
pp. 146040862097814
Author(s):  
Justin Vaida ◽  
Alexander DB Conti ◽  
Justin J Ray ◽  
Daniel A Bravin ◽  
Michelle A Bramer

Introduction Optimal management of lower extremity fractures includes early antibiotics administration, thorough irrigation and debridement, consideration of soft tissue injury, and definitive skeletal management. The purpose of this study was to evaluate the efficacy of topical vancomycin powder in the treatment of open lower extremity fractures. Methods This was a retrospective case control study in which open lower extremity fractures at our institution were reviewed for development of infection (including species and sensitivity if present) and the development of unanticipated wound complications requiring intervention. Patients from 2010-2015 were treated with standard of care consistent with evidence-based literature (IV antibiotics with external fixator, intramedullary nail, etc.). Patients from 2016–18 were additionally treated with vancomycin powder applied directly to the wound before closure. All patients were monitored per the treating surgeon’s standard follow-up protocol and had follow-up of at least two months. Results This retrospective case control study comprised 434 patients. The historical control group (n = 388 patients) and treatment group (n = 46 patients) were similar for age, sex, BMI (body mass index), diabetes, smoking status, and Injury Severity Score (ISS). There were 36 infections (9.28%) in the control group compared to four infections (8.70%) in the vancomycin powder group (p = 0.901). No significant difference was seen after adjusting for age, sex, BMI, diabetes, smoking status, and ISS. The vancomycin powder group experienced significantly more wound complications (15.2%) compared to the control group (6.4%; p = 0.039), which remained significant when adjusting for multiple covariates. Conclusions Topical vancomycin powder did not reduce the infection rate when applied in the surgical site of open lower extremity fractures. Instead, the addition of topical vancomycin powder resulted in significantly more wound complications in patients with open lower extremity fractures.


2020 ◽  
Vol 35 (4) ◽  
pp. 257-260
Author(s):  
Irini Chatziralli ◽  
Aristotelis Karamaounas ◽  
Eleni Dimitriou ◽  
Dimitrios Kazantzis ◽  
George Theodossiadis ◽  
...  

Diabetes Care ◽  
2004 ◽  
Vol 27 (5) ◽  
pp. 1143-1147 ◽  
Author(s):  
R. Wernich Thomsen ◽  
H. Holmager Hundborg ◽  
H.-H. Lervang ◽  
S. Paaske Johnsen ◽  
H. C. Schonheyder ◽  
...  

Diabetes Care ◽  
2012 ◽  
Vol 36 (2) ◽  
pp. 369-375 ◽  
Author(s):  
S.-W. Chen ◽  
Y.-T. Tsan ◽  
J.-D. Chen ◽  
H.-I. Hsieh ◽  
C.-H. Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document